🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 20454B104
- Market Cap
- Small Cap
Business: Compass Therapeutics, Inc. is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. The company pipeline of novel product candidates is designed to target multiple critical biological pathways required for an effective anti-tumor response.
Company Contact
- CEO
- Thomas J. Schuetz
- VPF
- Neil Lerner
- Headquarters
- 80 Guest St., Suite 60, Boston, MA 02135
- Phone
- 617-500-8099
- Investor Relations
- Mario Corso · 617-500-8099 · ir@compasstherapeutics.com